Salipada, Badria A.

HRN: 23-95-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/25/2023
10/31/2023
IV
1.5grams
Q6hrs
Infected Wounds, 1st Digit, Left Foot
Waiting Final Action 
10/25/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/25/2023
10/31/2023
IV
600mg
Q8hrs
Infected Wound, 1st Digit, Left Foot
Waiting Final Action 
10/25/2023
MUPIROCIN 2%, 15G (TUBE)
10/25/2023
10/31/2023
TOPICAL
2%
BID
Infected Wound, 1st Digit, Left Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: